Bionomics Competitors and Similar CompaniesClear all
Bionomics's competitors and similar companies include ViroStatics and Shanghai Junshi Biosciences.
 Bionomics Bionomics is a clinical-stage biopharmaceutical company developing ion channels targeting drug candidates designed for patients suffering from central nervous system (CNS) disorders. |  Shanghai Junshi Biosciences Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases. | ||
Founding Date | Founding Date 1996 | Founding Date 2005 | Founding Date 2012 |
Type | Type Subsidiary | Type Private | Type Public |
Tags | |||
Locations | Locations Eastwood, AU HQ | Locations Sassari, IT HQ Tramariglio, IT | Locations Shanghai, CN HQ |
Employees | Employees 7 | Employees 8 | Employees 2,578 |
Financial | |||
Revenue (est.) | Revenue (est.) $264k (FY, 2022) | Revenue (est.) N/A | Revenue (est.) ¥2.4b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥466.5m (FY, 2025) |
Gross profit | Gross profit $6.1m (FY, 2022) | Gross profit N/A | Gross profit ¥2b (FY, 2025) |
Net income | Net income ($21.8m) (FY, 2022) | Net income N/A | Net income (¥1b) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 10.4m | Total funding raised $ 53k | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Shanghai Junshi Biosciences
HQ
Shanghai, CN
Employees
2,578
Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.
View company